0
Skip to Content
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and AI
Private Equity/Investors
Case Studies
Consultants
History
Testimonials
Podcast
Press
Contact
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and AI
Private Equity/Investors
Case Studies
Consultants
History
Testimonials
Podcast
Press
Contact
Folder: Services▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and AI
Private Equity/Investors
Case Studies
Folder: About ▾
Back
Consultants
History
Testimonials
Podcast
Press
Contact
Uncategorized 4/28/05 Uncategorized 4/28/05

Senators step in to the drug safety debate

Read More
Uncategorized 4/27/05 Uncategorized 4/27/05

Hospital adds patient blogs to its website

Read More
Uncategorized 4/26/05 Uncategorized 4/26/05

Pharma has trouble recruiting patients for trials --could excessive exclusion criteria be the reason?

Read More
Uncategorized 4/26/05 Uncategorized 4/26/05

Grand Rounds is up at Dr. Tony's

Read More
Uncategorized 4/25/05 Uncategorized 4/25/05

Predictive modeling meets reality

Read More
Uncategorized 4/24/05 Uncategorized 4/24/05

800 pound gorillas can be friendly

Read More
Uncategorized 4/21/05 Uncategorized 4/21/05

FDA is gunning for Neurontin

Read More
Uncategorized 4/20/05 Uncategorized 4/20/05

Merck decides to compete with Canadian pharmacies

Read More
Uncategorized 4/19/05 Uncategorized 4/19/05

Health plans jump on the e-prescribing bandwagon

Read More
Uncategorized 4/18/05 Uncategorized 4/18/05

Big pharma tries to have it both ways on patents

Read More
Uncategorized 4/16/05 Uncategorized 4/16/05

90 day prescriptions at retail

Read More
Uncategorized 4/15/05 Uncategorized 4/15/05

Concierge practices fail to thrive: I'm neither surprised nor disappointed

Read More
Uncategorized 4/14/05 Uncategorized 4/14/05

Lessons for asthma drug makers in the COX-2 fiasco

Read More
Uncategorized 4/14/05 Uncategorized 4/14/05

Why the US will buy defibrillators and Europe won't

Read More
Uncategorized 4/12/05 Uncategorized 4/12/05

Medicare physician fee cut may really happen in 2006

Read More
Uncategorized 4/12/05 Uncategorized 4/12/05

Nevada tries to regulate emergency room wait time

Read More
Uncategorized 4/11/05 Uncategorized 4/11/05

A Change of Heart

Read More
Patients, Pharma, Policy and politics 4/8/05 Patients, Pharma, Policy and politics 4/8/05

I'm upset about the Bextra withdrawal

Read More
Uncategorized 4/7/05 Uncategorized 4/7/05

Stem cell funding in California triggers reactions back East

Read More
Uncategorized 4/6/05 Uncategorized 4/6/05

Encouraging signs of hospital transparency

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and AI
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Press
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2026 Health Business Group. All Rights Reserved.
Icons by Icon8